Lotus Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,435,000 | 0.543% |
Institutions | 18,259,755 | 6.9% |
Public Companies | 22,430,568 | 8.48% |
Private Companies | 108,968,519 | 41.2% |
General Public | 113,374,470 | 42.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
108,968,519 | NT$35.2b | 0% | no data | |||
17,517,348 | NT$5.7b | 0% | no data | |||
4,913,220 | NT$1.6b | 0% | no data | |||
4,209,375 | NT$1.4b | 2,410% | 1.34% | |||
2,262,571 | NT$730.8m | 0.04% | no data | |||
1,755,306 | NT$567.0m | 3.97% | no data | |||
1,498,502 | NT$484.0m | 436% | 0.26% | |||
1,229,000 | NT$397.0m | 0% | no data | |||
1,157,937 | NT$374.0m | 33.5% | no data | |||
1,130,000 | NT$365.0m | 0% | no data | |||
1,129,577 | NT$364.9m | 1,610% | 0.05% | |||
1,075,000 | NT$347.2m | 0% | 1.5% | |||
812,277 | NT$262.4m | 171% | 0.11% | |||
781,000 | NT$252.3m | -1.88% | 0.01% | |||
323,706 | NT$104.6m | 0% | 0.46% | |||
240,121 | NT$77.6m | -25% | 2.73% | |||
197,546 | NT$63.8m | -10.3% | 0.16% | |||
181,000 | NT$58.5m | -3.21% | no data | |||
150,000 | NT$48.5m | 0% | no data | |||
147,000 | NT$47.5m | 0% | no data | |||
144,979 | NT$46.8m | -0.3% | no data | |||
138,229 | NT$44.7m | 0% | 0.21% | |||
127,000 | NT$41.0m | 0% | no data | |||
104,000 | NT$33.6m | 18.2% | no data | |||
98,000 | NT$31.7m | 1.03% | no data |